Result of AGM

CRUSHMETRIC Group Limited
14 August 2023
 

14 August 2023

 

 

CRUSHMETRIC GROUP LIMITED

("CRUSHMETRIC" or "the Company")

 

RESULT OF ANNUAL GENERAL MEETING

 

 

CRUSHMETRIC Group Limited (AQSE: CUSH), the AQSE Growth Market quoted consumer design and production group is pleased to announce that at the Company's annual general meeting held on 11 August 2023, all resolutions were duly passed.

 

The Directors of the issuer accept responsibility for the contents of this announcement.

 

For further information, please contact:

 

   CRUSHMETRIC

ONG Ban Poh Michael - Chief Executive Officer

   Lilian Lo - Acting Chief Financial Officer

 

Tel: +852 2110 4221

   AQSE Growth Market Corporate Adviser

PETERHOUSE CAPITAL LIMITED

Guy Miller/Mark Anwyl

 

   Tel: +44 (0) 20 7469 0930

 

About CRUSHMETRIC Group Limited

The Company formerly engaged in TCM healthcare and skincare products in the past years. The incidence of Covid forced a change in focus and therefore, during 2022, the nature of the Company's operations and its principal activities have changed to acting as the holding company of a group engaged in (i) design and production that integrates shape changing technology ("CRUSH") into a catalogue of products that is designed and invented by a team led by the artist and co-founder of CRUSHMETRIC Limited, Noah Deledda. and (ii) the sale and distribution of the CRUSHMETRIC products through online and offline channels worldwide.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100